OBJECTIVES: To examine the effect of hepatitis C virus (HCV) on the prevalence of chronic kidney disease (CKD) among veterans with HIV and to evaluate independent associations of HCV and CKD with mortality. METHODS: We studied a national cohort of HIV-infected patients receiving care through the Veterans Healthcare Administration from 1998 to 2004. CKD was defined as an estimated glomerular filtration rate [eGFR (mL/min/1.73 m2)] < 60. Poisson regression was used to assess relationships between CKD, HCV, and mortality. RESULTS: Among 23,155 HIV-infected veterans, 12% had CKD. Forty percent of the cohort was coinfected with HCV, and a higher proportion of coinfected subjects had CKD compared with monoinfected subjects (14% vs 11%, P < 0.001). During the median follow-up of 7.6 years, 37% of subjects died and a graduated increase in adjusted mortality rates occurred with lower levels of eGFR (P < 0.001). Adjusted mortality rates were consistently higher in HCV-coinfected subjects across all levels of eGFR (P < 0.001). HCV was independently associated with increased mortality (incidence rate ratio 1.23, 95% confidence interval 1.17-1.29). CONCLUSIONS: CKD is prevalent in HIV-infected veterans and associated with substantially higher mortality. Compared with their monoinfected counterparts, veterans coinfected with HCV have significantly higher rates of CKD and mortality.
OBJECTIVES: To examine the effect of hepatitis C virus (HCV) on the prevalence of chronic kidney disease (CKD) among veterans with HIV and to evaluate independent associations of HCV and CKD with mortality. METHODS: We studied a national cohort of HIV-infectedpatients receiving care through the Veterans Healthcare Administration from 1998 to 2004. CKD was defined as an estimated glomerular filtration rate [eGFR (mL/min/1.73 m2)] < 60. Poisson regression was used to assess relationships between CKD, HCV, and mortality. RESULTS: Among 23,155 HIV-infected veterans, 12% had CKD. Forty percent of the cohort was coinfected with HCV, and a higher proportion of coinfected subjects had CKD compared with monoinfected subjects (14% vs 11%, P < 0.001). During the median follow-up of 7.6 years, 37% of subjects died and a graduated increase in adjusted mortality rates occurred with lower levels of eGFR (P < 0.001). Adjusted mortality rates were consistently higher in HCV-coinfected subjects across all levels of eGFR (P < 0.001). HCV was independently associated with increased mortality (incidence rate ratio 1.23, 95% confidence interval 1.17-1.29). CONCLUSIONS: CKD is prevalent in HIV-infected veterans and associated with substantially higher mortality. Compared with their monoinfected counterparts, veterans coinfected with HCV have significantly higher rates of CKD and mortality.
Authors: Lisa I Backus; Barbara R Phillips; Derek B Boothroyd; Larry A Mole; Jane Burgess; Michael O Rigsby; Sophia W Chang Journal: J Acquir Immune Defic Syndr Date: 2005-08-15 Impact factor: 3.731
Authors: Shawn L Fultz; Melissa Skanderson; Larry A Mole; Neel Gandhi; Kendall Bryant; Stephen Crystal; Amy C Justice Journal: Med Care Date: 2006-08 Impact factor: 2.983
Authors: Amy C Justice; Elaine Lasky; Kathleen A McGinnis; Melissa Skanderson; Joseph Conigliaro; Shawn L Fultz; Kristina Crothers; Linda Rabeneck; Maria Rodriguez-Barradas; Sharon B Weissman; Kendall Bryant Journal: Med Care Date: 2006-08 Impact factor: 2.983
Authors: Nina Weis; Bjarne O Lindhardt; Gitte Kronborg; Ann-Brit E Hansen; Alex L Laursen; Peer B Christensen; Henrik Nielsen; Axel Moller; Henrik T Sorensen; Niels Obel Journal: Clin Infect Dis Date: 2006-04-12 Impact factor: 9.079
Authors: Judith I Tsui; Eric Vittinghoff; Michael G Shlipak; Daniel Bertenthal; John Inadomi; Rudolph A Rodriguez; Ann M O'Hare Journal: Arch Intern Med Date: 2007-06-25
Authors: Amanda Mocroft; Ole Kirk; Jose Gatell; Peter Reiss; Panagiotis Gargalianos; Kai Zilmer; Marek Beniowski; Jean-Paul Viard; Schlomo Staszewski; Jens D Lundgren Journal: AIDS Date: 2007-05-31 Impact factor: 4.177
Authors: Raj K Medapalli; Chirag R Parikh; Kirsha Gordon; Sheldon T Brown; Adeel A Butt; Cynthia L Gibert; David Rimland; Maria C Rodriguez-Barradas; Chung-Chou H Chang; Amy C Justice; John Cijiang He; Christina M Wyatt Journal: J Acquir Immune Defic Syndr Date: 2012-08-01 Impact factor: 3.731
Authors: Robert C Kalayjian; Bryan Lau; Rhoderick N Mechekano; Heidi M Crane; Benigno Rodriguez; Robert A Salata; Zipporah Krishnasami; James H Willig; Jeffrey N Martin; Richard D Moore; Joseph J Eron; Mari M Kitahata Journal: AIDS Date: 2012-09-24 Impact factor: 4.177
Authors: Neel R Gandhi; Janet P Tate; Maria C Rodriguez-Barradas; David Rimland; Matthew Bidwell Goetz; Cynthia Gibert; Sheldon T Brown; Kristin Mattocks; Amy C Justice Journal: Pharmacoepidemiol Drug Saf Date: 2013-07-09 Impact factor: 2.890